Ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence StudyInterventional

Single Dose Crossover Comparative Bioavailability and Food Effect Study of Celecoxib 10 mg/1 mL Oral Suspension versus Celebrex®️ (celecoxib) 200 mg Capsules Following the Administration of a 200 mg Dose in Healthy Adult Volunteers / Fasting and Fed State.

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Bioequivalence Study

Sponsor

Codadose Inc.

Enrolment target

Start

28 Jun 2023

AUC (0-t), AUC (0-∞), and Cmax for celecoxib

Age 18 Years to any · Sex: All

Always speak to your GP or specialist before deciding to take part in a study.